Projects per year
Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit
Enzymes
Medicine & Life Sciences
Proteins
Medicine & Life Sciences
Catalytic Domain
Medicine & Life Sciences
Isotopes
Medicine & Life Sciences
Purine-Nucleoside Phosphorylase
Medicine & Life Sciences
Substrates
Chemical Compounds
Kinetics
Chemical Compounds
Mycobacterium tuberculosis
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects 1976 2023
Molecular Basis of Early Childhood Obesity Programming by Intrauterine Growth Restriction
3/1/18 → 2/28/23
Project: Research project › Research Project
Pediatric Obesity
T-Lymphocytes
DNA Methylation
Growth
Obesity
Function and Mechanism of Viperin, a radical SAM antiviral protein
6/26/17 → 5/31/19
Project: Research project › Exploratory/Developmental Grants
Cytidine Triphosphate
S-Adenosylmethionine
Antiviral Agents
Viruses
Proteins
Engineered, multispecific antibodies as broad anti-filovirus therapeutics
6/1/17 → 5/31/21
Project: Research project › Research Project
Ebolavirus
Monoclonal Antibodies
Antibodies
Marburgvirus
Viruses
Research Output 1973 2018
Advantages of Molecular Weight Identification during Native MS Screening
Khan, A., Bresnick, A., Cahill, S., Girvin, M., Almo, S. & Quinn, R. May 9 2018 (Accepted/In press) In : Planta Medica.Research output: Contribution to journal › Article
Molecular Weight
Ligands
Mass Spectrometry
Fourier Analysis
Proteins
A herpes simplex virus (HSV)-2 single-cycle candidate vaccine deleted in glycoprotein D protects male mice from lethal skin challenge with clinical isolates of HSV-1 and HSV-2
Burn, C., Ramsey, N., Garforth, S. J., Almo, S., Jacobs, W. R. & Herold, B. C. Mar 1 2018 In : Journal of Infectious Diseases. 217, 5, p. 754-758 5 p.Research output: Contribution to journal › Article
Human Herpesvirus 2
Human Herpesvirus 1
Glycoproteins
Vaccines
Skin
Anti-CTLA-4 therapy requires an Fc domain for efficacy
Ingram, J. R., Blomberg, O. S., Rashidian, M., Ali, L., Garforth, S., Fedorov, E., Fedorov, A. A., Bonanno, J. B., Le Gall, C., Crowley, S., Espinosa, C., Biary, T., Keliher, E. J., Weissleder, R., Almo, S. C., Dougan, S. K., Ploegh, H. L. & Dougan, M. Jan 1 2018 In : Proceedings of the National Academy of Sciences of the United States of America. 115, 15, p. 3912-3917 6 p.Research output: Contribution to journal › Article
CTLA-4 Antigen
Therapeutics
Thomsen-Friedenreich antibodies
Antibodies
New World Camelids